Internal Medicine, Pulmonary Disease · Anderson, IN
NPI
1205861242
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
2101 Jackson St, #110
Anderson, IN, 46016
Phone (765) 643-6012
Groups this clinician bills Medicare through
Medicare paid, 2024
$18K
594 services
Medicare patients, 2024
218
Average age 74
Drug cost, 2024
$1.5M
2,969 prescriptions
Company payments, 2025
$329
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Thomas Bright was code 99214 (office e&m - established), 173 times for 91 patients. In total Thomas Bright billed 594 services in 11 codes, and Medicare paid $18K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-04-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 173 | 91 | $81.30 | $14K |
| 94729 Pulmonary Function Testing | Facility | 134 | 128 | $5.80 | $777 |
| 94060 Pulmonary Function Testing | Facility | 117 | 112 | $6.71 | $785 |
| 94726 Pulmonary Function Testing | Facility | 84 | 80 | $7.79 | $654 |
| 94727 Pulmonary Function Testing | Facility | 43 | 42 | $8.08 | $347 |
| 94010 Pulmonary Function Testing | Facility | 19 | 18 | $5.10 | $96.92 |
By year: 2022 $28K for 761 services; 2023 $20K for 664 services; 2024 $18K for 594 services.
Medicare prescription drug claims, 2024
In 2024, the drug Thomas Bright prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 616 prescriptions and refills. In total Thomas Bright wrote 2,969 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 616 | 908 | 123 | $571K |
| Montelukast Sodium Generic | 490 | 1,267 | 130 | $5,663 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 435 | 602 | 133 | $13K |
| Methylprednisolone Generic | 149 | 159 | 61 | $2,383 |
| Breo Ellipta Fluticasone/Vilanterol | 111 | 125 | 21 | $50K |
| Azelastine Hcl Generic | 110 | 220 | 43 | $4,488 |
| Prednisone Generic | 89 | 106 | 29 | $284 |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 84 | 150 | 20 | $30K |
| Xolair Omalizumab | 80 | 85 | Under 11 | $253K |
| Spiriva Respimat Tiotropium Bromide | 64 | 102 | 18 | $51K |
| Arnuity Ellipta Fluticasone Furoate | 61 | 69 | 11 | $17K |
| Ventolin Hfa Albuterol Sulfate | 54 | 84 | 17 | $5,540 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 54 | 82 | Under 11 | $52K |
| Fluticasone Propionate Generic | 44 | 72 | 17 | $633 |
| Dexamethasone Generic | 40 | 40 | 11 | $220 |
Brand drugs: 1,686 claims; generic drugs: 1,283 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Thomas Bright $329 ($329 in general payments such as food, travel and fees) from 9 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $67.83.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 4 | $67.83 |
| Insmed, Inc. INSM | 3 | $65.95 |
| Amgen Inc. AMGN | 2 | $45.38 |
| Grifols USA, LLC | 2 | $45.01 |
| Genzyme Corporation SNY | 1 | $24.55 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 1 | $23.11 |
| GlaxoSmithKline, LLC. GSK | 1 | $22.57 |
| Mallinckrodt Hospital Products Inc. | 1 | $18.24 |
| Inspire Medical Systems, Inc. INSP | 1 | $16.22 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.